
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 61276-17-3 |
| Catalog No. | 2A-9045456 |
| Chinese Name | 毛蕊花糖苷; 麦角甾苷 |
| Synonyms | Acteoside; verbascoside; MFCD06798947 |
| Molecular Formula | C29H36O15 |
| Molecular Weight | 624.59 |
| Purity | 98.00 |
| Density | 1.6±0.1 g/cm3 |
| Boiling Point | 908.8±65.0 °C at 760 mmHg |
| Appearance | Solid;White to Yellow to Orange powder to crystal |
| Storage Condition | room temp |
| Application | Verbascoside is a glycoside obtained from Lantana camara. It is an ATP-competitive PKC inhibitor with an IC50 value of 25 µM. It has anti-tumor, anti-inflammatory, and anti-neuropathic pain effects. |
| PubChem ID | 329751494 |
| SMILES | CC1OC(OC2C(O)C(OCCc3ccc(O)c(O)c3)OC(CO)C2OC(=O)C=Cc2ccc(O)c(O)c2)C(O)C(O)C1O |
| InChI | InChI=1S/C29H36O15/c1-13-22(36)23(37)24(38)29(41-13)44-27-25(39)28(40-9-8-15-3-6-17(32)19(34)11-15)42-20(12-30)26(27)43-21(35)7-4-14-2-5-16(31)18(33)10-14/h2-7,10-11,13,20,22-34,36-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27+,28+,29-/m0/s1 |
| InChI Key | FBSKJMQYURKNSU-FSIAKBNXSA-N |
| Hazard Symbols | transportation |
| Bioactivity | Verbascoside is isolated from Lantana camara, acts as an ATP-competitive inhibitor of PKC, with an IC50 of 25 µM, and has antitumor, anti-inflammatory and antineuropathic pain activity. Related Catalog Research Areas >> Cancer Research Areas >> Inflammation/Immunology Research Areas >> Neurological Disease Natural Products >> Phenols Target PKC:25 μM (IC50) In Vitro Verbascoside acts as an ATP-competitive inhibitor of PKC, with an IC50 of 25 µM. Verbascoside shows Kis of 22 and 28 µM with respect to ATP and histone, respectively. Verbascoside has potent antitumor activity against L-1210 cells, with an IC50 of 13 µM[1]. Verbascoside (5, 10 µM) suppresses 2,4-dinitrochlorobenzene (DNCB)-induced T cell costimulatory factors CD86 and CD54, proinflammatory cytokines, and NFκB pathway activation in THP-1 cells[2]. In Vivo Verbascoside (1%) reduces the overall scratching behavior incidence as well as the severity of the skin lesions in 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD) mice model. Verbascoside also blocks DNCB-induced expression of proinflammatory cytokine TNF-α, IL-6, and IL-4 mRNA in skin lesions[2]. Verbascoside (50, 100 mg/kg, i.p.) does not modify chronic constriction injury (CCI)-induced cold allodynia. Verbascoside (200 mg/kg, i.p.) decreases hyper-sensitivity to cold stimulus, acetone, on day 3 in rats. Verbascoside also significantly reduces behavioral changes associated with neuropathy. Moreover, Verbascoside decreases Bax and increases Bcl-2 on day 3[3]. Cell Assay The lymphocytic mouse leukemia L1210 cells (ATCC, CCL 219) are plated sparsely at 104 cells per well in 24-well cluster plates in Dulbecco's modified Eagle medium containing 10% fetal calf serum, 4 mM glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin sulfate, and Verbascoside (solubilized in DMSO). After a 2-day incubation period at 37°C in a humidified atmosphere (5% CO2 in air), growth is monitored by counting cell numbers in a Coulter-counter. IC50 values are calculated on the basis of the linear regression lines established for each compound tested[1]. Animal Admin Rats[2] To induce atopic dermatitis (AD)-like symptoms, 2,4-dinitrochlorobenzene (DNCB) is used. Briefly, the dorsal hair of the mice is removed using an electronic clipper 2 days before DNCB treatment. An application of 200 µL of 1% DNCB (in acetone:olive oil = 4:1) is made to the shaved dorsal skin for sensitization. The repeated challenge is performed on the same site with 0.2% DNCB once every 3 days for about 2 weeks. The mice are divided into 4 groups (n = 6 per group): (1) vehicle-treated controls, (2) DNCB-treated only, (3) 1% Verbascoside (in acetone:olive oil 4:1)-treated only, and (4) DNCB + 1% Verbascoside-treated group[2]. References [1]. Herbert JM, et al. Verbascoside isolated from Lantana camara, an inhibitor of protein kinase C. J Nat Prod. 1991 Nov-Dec;54(6):1595-600. [2]. Li Y, et al. Verbascoside Alleviates Atopic Dermatitis-Like Symptoms in Mice via Its Potent Anti-Inflammatory Effect. Int Arch Allergy Immunol. 2018;175(4):220-230. [3]. Amin B, et al. The Effect of Verbascoside in Neuropathic Pain Induced by Chronic Constriction Injury in Rats. Phytother Res. 2016 Jan;30(1):128-35. Chemical & Physical Properties Density 1.6±0.1 g/cm3 Boiling Point 908.8±65.0 °C at 760 mmHg Molecular Formula C29H36O15 Molecular Weight 624.587 Flash Point 294.7±27.8 °C Exact Mass 624.205444 PSA 245.29000 LogP 2.44 Vapour Pressure 0.0±0.3 mmHg at 25°C Index of Refraction 1.689 InChIKey FBSKJMQYURKNSU-FSIAKBNXSA-N SMILES CC1OC(OC2C(O)C(OCCc3ccc(O)c(O)c3)OC(CO)C2OC(=O)C=Cc2ccc(O)c(O)c2)C(O)C(O)C1O Storage condition room temp |
| Use of | Verbascoside is isolated from Lantana camara, acts as an ATP-competitive inhibitor of PKC, with an IC50 of 25 µM, and has antitumor, anti-inflammatory and antineuropathic pain activity. Properties Articles28 Name Verbascoside Synonym More Synonyms Acteoside Biological Activity Description Verbascoside is isolated from Lantana camara, acts as an ATP-competitive inhibitor of PKC, with an IC50 of 25 µM, and has antitumor, anti-inflammatory and antineuropathic pain activity. Related Catalog Research Areas >> Cancer Research Areas >> Inflammation/Immunology Research Areas >> Neurological Disease Natural Products >> Phenols PKC:25 μM (IC50) References [1]. Herbert JM, et al. Verbascoside isolated from Lantana camara, an inhibitor of protein kinase C. J Nat Prod. 1991 Nov-Dec;54(6):1595-600. [2]. Li Y, et al. Verbascoside Alleviates Atopic Dermatitis-Like Symptoms in Mice via Its Potent Anti-Inflammatory Effect. Int Arch Allergy Immunol. 2018;175(4):220-230. [3]. Amin B, et al. The Effect of Verbascoside in Neuropathic Pain Induced by Chronic Constriction Injury in Rats. Phytother Res. 2016 Jan;30(1):128-35. Chemical & Physical Properties Molecular Formula C29H36O15 Exact Mass 624.205444 PSA 245.29000 Index of Refraction 1.689 InChIKey FBSKJMQYURKNSU-FSIAKBNXSA-N Storage condition room temp |
| Transport Info | Product name: Purity: 97.0% |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: No dangerous goods IMDG Code: No dangerous goods International Air Transport Dangerous Regulations: No dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special precautions for users No data available |
| Related Products in Botanical Reference Standards | ||
|---|---|---|
| Decyl-beta-D-glucopyranoside | 58846-77-8 | 2A-9045073 |
| Hexyl beta-D-glucopyranoside | 59080-45-4 | 2A-9045107 |
| Dodecyl-beta-D-glucopyranoside | 59122-55-3 | 2A-9045117 |
| Cholesterol-26,26,26,27,27,27-D6 | 60816-17-3 | 2A-9045387 |
| Cyanomethyl 2,3,4,6-tetra-O-acetyl-1-thio-beta-D-galactopyranoside | 61145-33-3 | 2A-9045429 |
| Schisandrin A | 61281-38-7 | 2A-9045462 |
| Isoacteoside | 61303-13-7 | 2A-9045467 |
| Ginsenoside F2 | 62025-49-4 | 2A-9045641 |
| Pinoresinol diglucoside | 63902-38-5 | 2A-9045984 |
| 3-Carboxyumbelliferyl beta-D-galactopyranoside | 64664-99-9 | 2A-9046129 |
| Browse all Botanical Reference Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA